Skip to main content
. 2001 Jun 12;98(13):7528–7533. doi: 10.1073/pnas.131187998

Figure 1.

Figure 1

General description of our prodrug activation strategy by antibody-catalyzed retro-aldol/retro-Michael reaction sequence. The activation sequence catalyzed by 38C2 is depicted for the drug-masking linker. Catalytic cleavage of the trigger by retro-aldol/retro-Michael reactions of the linker is followed by spontaneous decarboxylation, cyclization, and release of the free drug.